COM:CORVUSPHARMA
Corvus Pharmaceuticals
- Stock
locale
United States
market
STOCKSindustry
Biotechnology Researchwebsite
corvuspharma.comcrunchbase
corvus-pharmaceuticalslinkedin
corvus-pharmaceuticalsfounding date
Jan 01, 2014ipo date
Mar 23, 2016
Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Phase Ib/II clinical trial for non-small cell lung cancer and head and neck cancers. The company also develops CPI-818, a covale...Show More